TCL Archive A Message From NCI: “We Deeply Regret The Need To Eliminate This Program.” AP4 Applicants And Corporate Partners Spent Years, Money, Before NCI Pulled The Plug On Novel Public-Private Partnerships. Von Eschenbach Called AP4 “A New Paradigm” For Drug Development. NCI Executive Committee “Prioritized” Programs. April 21, 2006
TCL Archive More Cost-Effective To Use Cetuximab In Patients With Wild-Type KRAS Gene August 28, 2009
TCL Archive NCI, Dept. of Veteran’s Affairs Sign Agreement On Clinical Trials Access November 1, 1996
